In hematologic neoplasms, CCL2/CCR2 axis has been investigated in Acute Myeloid Leukemia (AML) [86], multiple myeloma [87], and systemic mastocytosis [88]. This evidence concerns the gene CCL2 and acute myeloid leukemia.